Paricalcitol

In the US, Paricalcitol (paricalcitol systemic) is a member of the drug class vitamins and is used to treat Secondary Hyperparathyroidism.

US matches:

• Paricalcitol


• Paricalcitol Capsules

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

H05BX02

CAS registry number (Chemical Abstracts Service)

0131918-61-1

Chemical Formula

C27-H44-O3

Molecular Weight

416

Therapeutic Category

Vitamin D analogue

Chemical Name

(7E,22E)-19-nor-9,10-secoergosta-5,7,22-triene-1α,3ß,25-triol (WHO)

Foreign Names

• Paricalcitolum (Latin)
• Paricalcitol (German)
• Paricalcitol (French)
• Paricalcitol (Spanish)

Generic Names

• Paricalcitol (OS: USAN)
• 19-Nor-1-α-25-Dihydroxyvitamin D₂! (IS)
• ABT 358 (IS: Abbott)
• Compound 49510 (IS)
• Paricalcitol (PH: USP 32)

Brand Names

• Zemplar
  Abbott, Austria; Abbott, Australia; Abbott, Switzerland; Abbott, Colombia; Abbott, Czech Republic; Abbott, Germany; Abbott, Denmark; Abbott, Spain; Abbott, Finland; Abbott, United Kingdom; Abbott, Hong Kong; Abbott, Croatia (Hrvatska); Abbott, Hungary; Abbott, Ireland; Abbott, Italy; Abbott, Luxembourg; Abbott, Mexico; Abbott, Netherlands; Abbott, Norway; Abbott, Oman; Abbott, Poland; Abbott, Portugal; Abbott, Serbia; Abbott, Sweden; Abbott, Singapore; Abbott, Slovenia; Abbott, Turkey; Abbott, Taiwan; Abbott, United States; Abbott, Venezuela

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.